Results 51 to 60 of about 2,705 (182)

Estimating the economic burden of typhoid in children and adults in Blantyre, Malawi: A costing cohort study

PLoS ONE, 2022
Background Typhoid causes preventable death and disease. The World Health Organization recommends Typhoid Conjugate Vaccine for endemic countries, but introduction decisions depend on cost-effectiveness.
Fumbani Limani, Christopher Smith, Richard Wachepa, Hlulose Chafuwa, James Meiring, Patrick Noah, Pratiksha Patel, Priyanka D. Patel, Frédéric Debellut, Clint Pecenka, Melita A. Gordon, Naor Bar-Zeev   +11 more
doaj   +2 more sources

Immune response of S. Typhi-derived Vi polysaccharide and outer membrane protein a conjugate in mice

Pediatrics and Neonatology, 2023
Typhoid fever is a serious concern precisely in developing nations. Still investigators are exploring a better conjugate partner for Vi-polysaccharide to develop a more effective vaccine for typhoid fever. Here, we cloned and expressed S.
Shabirul Haque, Sanjukta Sengupta, Azhar Khan, Asok Kumar Mukhopadhyay, Maharaj Kishan Bhan, Ramesh Kumar, Bansilal Jailkhani   +6 more
doaj   +1 more source

Prevention of enteric fever in travellers with typhoid conjugate vaccines [PDF]

Journal of Travel Medicine, 2018
The 2018 WHO position paper on typhoid vaccines indicates preference for the use of new generation typhoid conjugate vaccines over existing parenteral Vi-polysaccharide (Vi-PS) and oral attenuated Ty21a ...
Britto, C, Jin, C, Theiss-Nyland, K, Pollard, A   +3 more
openaire   +2 more sources

Predicting the Impact of Typhoid Conjugate Vaccines on Antimicrobial Resistance [PDF]

Clinical Infectious Diseases, 2019
Abstract Background Empiric prescribing of antimicrobials in typhoid-endemic settings has increased selective pressure on the development of antimicrobial-resistant Salmonella enterica serovar Typhi.
Kaufhold, Samantha, Yaesoubi, Reza, Pitzer, Virginia E   +2 more
openaire   +2 more sources

New vaccine adoption: qualitative study of national decision-making processes in seven low- and middle-income countries. [PDF]

, 2012
As more new and improved vaccines become available, decisions on which to adopt into routine programmes become more frequent and complex. This qualitative study aimed to explore processes of national decision-making around new vaccine adoption and to ...
Chavez, E, Biellik, R, Konate, M, Molla, M, Mounier-Jack, S, Griffiths, UK, Burchett, HED, Ongolo-Zogo, P, Uddin, J, Wakasiaka, S, Mills, A, Sarma, H, Gilson, L, Kitaw, Y   +13 more
core   +1 more source

Synthetic O‐Polysaccharide Backbone Units for a Single Antigen Vaccine Against Two Major Non‐Typhoidal Salmonella Serovars

Angewandte Chemie, Volume 138, Issue 26, 22 June 2026.
A modular strategy was developed to synthesize tri‐, hexa‐, and nona‐saccharides representing repeating units of the conserved O‐polysaccharide backbone of Salmonella. Conjugates of these glycans to bacteriophage Qβ induced strong IgG responses in mice and rabbits. Antibodies elicited recognized native O‐polysaccharides and conferred protection against
Xingling Pan, Changxin Huo, Soham Maity, Herbert Kavunja, Rachel Moszyk, Cameron Talbot, Scott M. Baliban, Xuefei Huang   +7 more
wiley   +2 more sources

Conjugate vaccines for enteric fever: proceedings of a meeting organized in New Delhi, India in 2009

Journal of Infection in Developing Countries, 2010
Enteric fever is responsible for significant morbidity in South Asia and high prevalence of severe disease is seen in children under two years of age. Effective typhoid vaccines are available, but they cannot be used for children under two years of age
Audino Podda, Allan James Saul, Rashmi Arora, Zulfiqar Bhutta, Anju Sinha, Rajni Gaind, Tanu Singhal, Samir Saha, Abdullah Brooks, Laura B. Martin, Yeshwant Amdekar, Amar Jeet Chitkara, Mae Shieh, Ambujam Nair Kapur, Tulsi Das Chugh   +14 more
doaj   +1 more source

Research priorities to support typhoid conjugate vaccine decision-making in India: evidence assessment and stakeholder survey. [PDF]

BMJ Public Health
BACKGROUND: India has a high typhoid fever burden. In 2022, the National Technical Advisory Group on Immunisation recommended introducing typhoid conjugate vaccine (TCV) into the Universal Immunisation Programme.
Mogasale VV, Sinha A, John J, Hasan Farooqui H, Ray A, Chantler T, Mogasale V, Dhoubhadel BG, Edmunds WJ, Clark A, Abbas K.   +10 more
europepmc   +2 more sources

Parting the Clouds over Typhoid with a New Conjugate Vaccine [PDF]

New England Journal of Medicine, 2019
Typhoid fever is caused by fecal–oral transmission of Salmonella enterica serovar Typhi (S. Typhi).
Marks, Florian, Kim, Jerome H
openaire   +2 more sources

Field evaluation of typhoid conjugate vaccine in a catch-up campaign among children aged 9 months to 15 years in Sindh, Pakistan

, 2022
Background: Typhoid conjugate vaccine (TCV) has recently been introduced in the expanded program for immunization (EPI) in Pakistan. Before its introduction in routine immunization, a onetime catchup cam-paign among children 9 months to 15 years old was ...
Seema Irfan, Andreas Mårtensson, Rafey, Abdul,, Rozina S. Thobani, Mårtensson, Andreas,, Abdul Rafey, Shazia Sultana, Mohammad Tahir Yousafzai, Sultana, Shazia,, Brown, Nick,, Nick Brown, Ayub Khan, Irfan, Seema,, Muhammad Jan, Ujjan, Ikram Uddin,, Kazi, Abdul Momin,, Jan, Muhammad,, Khan, Ayub,, Abdul Momin Kazi, Farah Naz Qamar, Ikram Uddin Ujjan, Thobani, Rozina S.,, Yousafzai, Mohammad Tahir,, Qamar, Farah Naz,   +23 more
core   +1 more source